Elevance Health Raises 2026 Outlook, Beats Estimates

Elevance Health Inc. reported impressive third-quarter financial results, exceeding analyst expectations.

The company announced adjusted earnings per share of $6.99, significantly surpassing the consensus estimate. Operating revenue for the quarter stood at $50.4 billion, marking a 0.7% year-over-year increase from the previous year's third quarter.

Driven by strong performance, Elevance Health has raised its full-year 2026 adjusted earnings per share guidance to at least $29.00, exceeding prior analyst consensus. The company also increased its full-year operating cash flow projection to a minimum of $6.5 billion.

Medical membership totaled approximately 44.9 million as of September 30, 2026, a slight decrease year-over-year. The Health Benefits segment saw a 3% revenue increase, while the Carelon segment reported a 5% revenue rise and a 17% gain in operating profit.

The company declared a fourth-quarter dividend of $1.72 per share, scheduled for payment on December 18, 2026. Elevance Health's CEO expressed confidence in continued growth, targeting at least 12% adjusted diluted earnings per share growth in 2027.